Ketofol is one of 26 small molecule programs targeting Inguinal hernia. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
30 competitors in Inguinal Hernia
Naropin
Marcaine
Precedex
Ancef
Garamycin
Iheezo
Advil
Oxycontin
Neurontin
Cymbalta
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details